Latest Whitepapers

In this paper, we demonstrate how the GeneArt Gibson Assembly HiFi Cloning Kit can be used with multiple Invitrogen™ GeneArt™ Strings DNA Fragments to produce large constructs in highly efficient reactions.

This whitepaper explores three unique case studies, showing how TEMs can be applied in diagnostics. Learn how to fine tune pore size and density to reliably capture target cells, ensure quality manufacturing and benefit downstream analysis.

This whitepaper explores the advantages of a novel cell sorting and dispensing platform – which combines microfluidics, flow cytometry and liquid dispensing – that can help researchers get to their optimal clones more efficiently.

This article explores how we can find new ways to stop tumor growth and prevent drug resistance by targeting the language of cancer cell communication.

As biopharmaceutical companies scale up manufacturing, many are turning to outsourcing for buffer and process liquid preparation. But before making this decision, organizations must carefully weigh up various factors, including manufacturing space, personnel requirements and analytical capabilities.

When assessing PARP enzymatic activity for drug development, each component must be carefully optimized to ensure sensitivity, robustness and reproducibility. This whitepaper explores methods and reagents available to evaluate drug specificity and effectiveness.

This whitepaper describes the technology behind this versatile immunoassay, providing an in-depth exploration of its principles, methodologies and diverse applications.

This whitepaper explores the tools available to characterize antibody binding to Fc receptors, including quantitative assays to support optimization of therapeutic products.

This brochure explores the applications of a real-time metabolic analysis platform for cancer research and cell therapeutics development.

Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.